NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/11/2025
Voltar para busca
Dado oficial do USPTO
TSURE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10
Data de depósito
16/09/2022
Data de registro
23/07/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/07/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
FR
Examinador
CARR, PATRICK C
Unidade examinadora
N70
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized wording "TSURE".
Titulares e representantes
Titulares
S. F. (pessoa física)
Representantes
Charles Ho Barron & Young PLLC
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
diagnostic reagents for medical use; reagents for use in medical genetic testing; medical diagnostic products for bacteriological culturesmedical diagnostic reagents; chemical preparations for pharmaceutical usefor treating infectious diseasesinflammatory and neoplastic diseasesdigestive diseasesrespiratory diseasescirculatory diseasesimmune system diseases; chemical preparations for medical usefor treating infectious diseasesinflammatory and neoplastic diseasesdigestive diseasesrespiratory diseasescirculatory diseasesimmune system diseases; diagnostic preparations for medical use; diagnostic kits for medical diagnostic purposes consisting of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectionfor the detection of cancerinfectious diseasesinflammatory disorders and oncological disorders; purified biochemicalsprotein arraysfluorescent enzymes and dyes for use as reagents for medical diagnostics; chemical reagents for medical and veterinary use; biochemical preparations for medical use being chemical preparations for the diagnosis of pregnancy; diagnostic biomarking reagents for medical use; all of the aforementioned goods are not for use with infusion sets; ointments for pharmaceutical use being antibiotic ointments; antibiotic ointments; anti-inflammatory ointments; medicinal ointments for treating dermatological conditions; food for babies; dietary supplements for humans and animals for the mouth to be taken in the nature of tabletscapsules and gel capsules; dental waxes
Classe 10
blood testing apparatus; x-ray diagnostic apparatus; testing apparatus for medical usegenetic testing apparatus for medical purposes; diagnostic imaging apparatus for medical useelectromagnetic medical diagnostic imaging apparatus; apparatus for testing bacteria and virusesmedical diagnostic apparatus for testing for viruses and bacteria; DNA extraction and purification apparatus for medical useapparatus for DNA testing for medical purposes; medical apparatus and instruments for RNA analysisother than for dental useapparatus for RNA testing for medical purposes; body composition analyzers for medical use; diagnostic apparatus for medical and veterinary usein particular for detecting nucleic acid molecules in a samplein particular in a patient samplemedical apparatus and instruments for diagnostic use for testing for hereditary diseasesinfectious diseasesinflammatory and neoplastic diseasesdigestive diseasesrespiratory diseasescirculatory diseasesimmune system diseases; analysis devices for identification of bacteria for medical usemedical instruments for analysing and identifying bacteria; DNA and RNA testing apparatus for medical use; genetic testing apparatus for medical use; medical devicesnucleic acid analyzer for medical diagnosticsmedical apparatus and instruments for diagnostic use for testing for hereditary diseasesinfectious diseasesinflammatory and neoplastic diseasesdigestive diseasesrespiratory diseasescirculatory diseasesimmune system diseases; immunochemical testing apparatus for medical use; all of the aforementioned goods do not consist of infusion setsare not for use with infusion sets
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/01/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/01/2025
FIMP
FINAL DISPOSITION PROCESSED
06/01/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/10/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
23/07/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
30/06/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/06/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/06/2024
GPNX
NOTIFICATION PROCESSED BY IB
08/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/05/2024
PUBO
PUBLISHED FOR OPPOSITION
07/05/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/04/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/04/2024
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/03/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
15/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/03/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
13/03/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
13/03/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
12/02/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/01/2024
GNFR
FINAL REFUSAL E-MAILED
02/01/2024
CNFR
FINAL REFUSAL WRITTEN
02/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/11/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/11/2023
RFNT
REFUSAL PROCESSED BY IB
04/09/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/08/2023
RFRR
REFUSAL PROCESSED BY MPU
11/08/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/07/2023
CNRT
NON-FINAL ACTION WRITTEN
06/07/2023
DOCK
ASSIGNED TO EXAMINER
28/06/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/01/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
30/12/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TSURE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.